May 13, 2026 05:46AM
May 13, 2026 02:38AM
Jan 29, 2026 01:37AM
Jan 15, 2026 07:52AM
Nov 5, 2025 08:03AM
Oct 30, 2025 04:11AM
Oct 30, 2025 03:04AM Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filin
Jul 30, 2025 05:14PM
Jul 30, 2025 02:41AM
May 8, 2025 02:36AM
Apr 2, 2025 04:50AM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM
Jan 30, 2025 01:35AM Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
Nov 7, 2024 07:00AM
Oct 31, 2024 02:05AM
Aug 6, 2024 04:01PM
Jul 31, 2024 02:06AM
Jun 1, 2024 08:00AM
May 9, 2024 04:10AM
May 9, 2024 02:07AM Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
Feb 1, 2024 01:02AM
Dec 21, 2023 07:35AM
Oct 26, 2023 02:00AM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:30PM
Oct 17, 2023 07:30PM Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
Aug 7, 2023 04:01PM
Jul 27, 2023 02:00AM
May 11, 2023 02:40AM
May 2, 2023 04:01PM
Feb 2, 2023 05:40AM
Feb 2, 2023 01:00AM
Dec 13, 2022 07:00AM Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
Oct 27, 2022 02:00AM
Aug 11, 2022 10:01AM
Jul 28, 2022 02:00AM
May 11, 2022 02:15AM
Apr 19, 2022 05:55AM
Apr 18, 2022 10:33PM
Feb 3, 2022 05:42AM Takeda Pharmaceutical (TAK) Reports Q3 EPS of JPY 154
Feb 3, 2022 01:13AM
Nov 17, 2021 08:33AM
Oct 28, 2021 02:15AM
Aug 1, 2021 07:30PM
Jul 30, 2021 02:00AM
May 11, 2021 02:35AM
Apr 14, 2021 06:30AM Centogene N.V. (CNTG) Extends Partnership With Takeda (TAK)
Apr 14, 2021 06:30AM

1,198,563 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All